BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8689953)

  • 1. Metabolism of bromodichloroacetate in B6C3F1 mice.
    Xu G; Stevens DK; Bull RJ
    Drug Metab Dispos; 1995 Dec; 23(12):1412-6. PubMed ID: 8689953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pretreatment with dichloroacetate or trichloroacetate on the metabolism of bromodichloroacetate.
    Austin EW; Bull RJ
    J Toxicol Environ Health; 1997 Nov; 52(4):367-83. PubMed ID: 9354181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
    Bull RJ; Sasser LB; Lei XC
    Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
    Abbas R; Fisher JW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice.
    Templin MV; Parker JC; Bull RJ
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):1-8. PubMed ID: 8236248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
    Abbas RR; Seckel CS; Kidney JK; Fisher JW
    Drug Metab Dispos; 1996 Dec; 24(12):1340-6. PubMed ID: 8971140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA).
    Stauber AJ; Bull RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):235-46. PubMed ID: 9194407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of dihalogenated and trihalogenated acetates in the liver of B6C3F1 mice.
    Kato-Weinstein J; Stauber AJ; Orner GA; Thrall BD; Bull RJ
    J Appl Toxicol; 2001; 21(2):81-9. PubMed ID: 11288130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichloroacetate and trichloroacetate promote clonal expansion of anchorage-independent hepatocytes in vivo and in vitro.
    Stauber AJ; Bull RJ; Thrall BD
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):287-94. PubMed ID: 9653059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice.
    Merdink JL; Gonzalez-Leon A; Bull RJ; Schultz IR
    Toxicol Sci; 1998 Sep; 45(1):33-41. PubMed ID: 9848108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water.
    Gonzalez-Leon A; Schultz IR; Xu G; Bull RJ
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):189-95. PubMed ID: 9344886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice.
    Larson JL; Bull RJ
    Toxicol Appl Pharmacol; 1992 Aug; 115(2):268-77. PubMed ID: 1641860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats. Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate.
    James MO; Yan Z; Cornett R; Jayanti VM; Henderson GN; Davydova N; Katovich MJ; Pollock B; Stacpoole PW
    Drug Metab Dispos; 1998 Nov; 26(11):1134-43. PubMed ID: 9806957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the peroxisome proliferator-activated receptor alpha (PPARalpha) in responses to trichloroethylene and metabolites, trichloroacetate and dichloroacetate in mouse liver.
    Laughter AR; Dunn CS; Swanson CL; Howroyd P; Cattley RC; Corton JC
    Toxicology; 2004 Oct; 203(1-3):83-98. PubMed ID: 15363585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of perchloroethene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid, and N-acetyl-S-(trichlorovinyl)-L-cysteine in rats and humans after inhalation.
    Völkel W; Friedewald M; Lederer E; Pähler A; Parker J; Dekant W
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):20-7. PubMed ID: 9875296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of trichloroacetic acid and dichloroacetic acid in the isolated perfused rat liver.
    Toxopeus C; Frazier JM
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):90-8. PubMed ID: 9772204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pre-treatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice.
    Gonzalez-Leon A; Merdink JL; Bull RJ; Schultz IR
    Chem Biol Interact; 1999 Dec; 123(3):239-53. PubMed ID: 10654841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of chloral hydrate and its metabolites in male human volunteers.
    Merdink JL; Robison LM; Stevens DK; Hu M; Parker JC; Bull RJ
    Toxicology; 2008 Mar; 245(1-2):130-40. PubMed ID: 18243465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichloroacetate- and trichloroacetate-induced phagocytic activation and production of oxidative stress in the hepatic tissues of mice after acute exposure.
    Hassoun EA; Dey S
    J Biochem Mol Toxicol; 2008 Feb; 22(1):27-34. PubMed ID: 18273911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.